Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Ontruzant launches to become first Herceptin biosimilar available in the UK

March 8, 2018 Sales and Marketing Cancer, Herceptin, MSD, Ontruzant, Roche, Samsung Bioepis, pharma

Ontruzant, the biosimilar version of Herceptin (trastuzumab ) originally developed by Korean firm Samsung Bioepis, has launched for patients in …
News

EvoTec to command vast Sanofi resources in infectious disease R&D partnership

March 8, 2018 Research and Development, Sales and Marketing Evotec, Sanofi, infectious disease, infective disease, pharma

Sanofi has announced it is to team up with biotech drug discovery specialist EvoTec to leverage a new open innovation …
News

Eisai and MSD team up to combine Lenvima and Keytruda in cancer

March 8, 2018 Sales and Marketing Cancer, Eisai, Kidney cancer, Lenvima, MSD, Merck, keytruda, pharma

Pharma heavyweights MSD (Merck) and Eisai have announced they are to join forces to develop and commercialise the latter’s tyrosine …
News

Sanofi’s controversial dengue vaccine may still hit US market, despite Philippines disaster

March 7, 2018 Sales and Marketing FDA, Philippines, Sanofi, US, dengue, dengvaxia, pharma

Sanofi has revealed that the ongoing debacle in the Philippines concerning its dengue vaccine Dengvaxia has not deterred it from …
News

FDA greenlights alternative therapy for multidrug-resistant HIV patients

March 7, 2018 Research and Development, Sales and Marketing HIV, Theratechnologies, Trogarzo, pharma

Theratechnologies has revealed that Trogarzo has received approval from the FDA as a treatment of HIV-1 in patients with multidrug-resistant …
News

Former Sanofi exec accused of sexting and indecent exposure demands €1.2m

March 7, 2018 Research and Development, Sales and Marketing Sanofi, pharma

A former Sanofi executive fired for sexting, indecent exposure and other alleged sexual harassment charges has been demanding up to …
News

Japan saves record $12.2bn in 2017 through greater generic use

March 7, 2018 Research and Development, Sales and Marketing Japan, generics, keytruda, opdivo, pharma

Through a concerted shift from branded drugs to generic equivalents as a means to lower prescription costs, Japan is estimated …
News

FDA authorises first direct-to-consumer test for BRCA mutations, with caveats

March 6, 2018 Research and Development, Sales and Marketing 23andME, BRCA, Cancer, FDA, breast cancer, ovarian cancer, pharma

The FDA has given its authorisation to the first ever direct-to-consumer (DTC) test to identify three BRCA gene mutations which …
News

Martin Shkreli ordered to forfeit $7.36m ahead of fraud sentencing

March 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Martin Shkreli, pharma

Reviled pharma bro Martin Shkreli is experiencing another heavy dose of karma after a US judge ordered him to forfeit …
News

Uncovering trends in the future of real world data

March 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, AstraZeneca, feature, pharma, real world data, real world evidence

A new report has canvassed the intentions of industry players in the use of real world data and evidence over …
Feature

Gilead investigational data gives hope for HIV eradication in humans

March 5, 2018 Research and Development, Sales and Marketing Gilead, HIV, pharma

Gilead has lifted the curtain on new preclinical data on the efficacy of a combo therapy of GS-9620, its investigational …
News

FDA finds major manufacturing issues at key Aurobindo facility

March 5, 2018 Manufacturing and Production, Sales and Marketing Aurobindo, FDA, pharma

Indian pharmaceutical firm Aurobindo has been rocked by an USFDA review which identified nine major issues with its Unit 4 …
News

Celgene strikes $101m partnership in oncology, neurodegenerative and inflammatory

March 5, 2018 Research and Development, Sales and Marketing Cancer, Celgene, Vividion, inflammatory, neurodegenerative, oncology, pharma

Celgene has inked a new multi-year partnership with biotech firm Vividion Therapeutics to leverage the latter’s proteomics and chemistry platforms …
News

NHS trials “world-leading” initiative to cut prostate cancer diagnoses to just days

March 5, 2018 Research and Development, Sales and Marketing Cancer, MRI, NHS, pharma, prostate cancer

The NHS has revealed plans to cut the average diagnosis times for prostate cancer from six weeks to less than …
News

Abbvie and Biogen pull MS drug Zinbryta following urgent EMA safety review

March 5, 2018 Sales and Marketing AQbbvie, Biogen, EMA, Europe, mulyiple sclerosis, pharma, zinbryta

Biogen and Abbvie have announced their intention to voluntarily withdraw their multiple sclerosis therapy Zinbryta (daclizumab) from all global markets …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026